» Articles » PMID: 35682502

Determinants of COVID-19 Vaccine Acceptance and Uptake in a Transborder Population at the Mexico-Guatemala Border, September-November 2021

Abstract

Assessing COVID-19 vaccination uptake of transborder populations is critical for informing public health policies. We conducted a probability (time-venue) survey of adults crossing from Mexico into Guatemala from September to November 2021, with the objective of describing COVID-19 vaccination status, willingness to get vaccinated, and associated factors. The main outcomes were receipt of ≥1 dose of a COVID-19 vaccine, being fully vaccinated, and willingness to get vaccinated. We assessed the association of outcomes with sociodemographic characteristics using logistic regressions. Of 6518 participants, 50.6% (95%CI 48.3,53.0) were vaccinated (at least one dose); 23.3% (95%CI 21.4,25.2) were unvaccinated but willing to get vaccinated, and 26.1% (95%CI 24.1,28.3) were unvaccinated and unwilling to get vaccinated. Those living in Mexico, independent of country of birth, had the highest proportion vaccinated. The main reason for unwillingness was fear of side effects of COVID-19 vaccines (47.7%, 95%CI 43.6,51.9). Education level was positively associated with the odds of partial and full vaccination as well as willingness to get vaccinated. People identified as Catholic had higher odds of getting vaccinated and being fully vaccinated than members of other religious groups or the non-religious. Further studies should explore barriers to vaccination among those willing to get vaccinated and the motives of the unwilling.

Citing Articles

Cross-border use of health services: An exploratory mixed-methods project at the Mexico-Guatemala border.

Bojorquez I, Arevalo M, Chavez A, Gomez-Osorio R, Rodriguez-Chavez C, Leyva R PLOS Glob Public Health. 2024; 4(11):e0003685.

PMID: 39565734 PMC: 11578442. DOI: 10.1371/journal.pgph.0003685.


Diabetes is associated with increased risk of death in COVID-19 hospitalizations in Mexico 2020: A retrospective cohort study.

Huang A, Huang S Health Sci Rep. 2023; 6(7):e1416.

PMID: 37415678 PMC: 10320697. DOI: 10.1002/hsr2.1416.


A characterization of cross-border use of health services in a transborder population at the Mexico-Guatemala border, September-November 2021.

Rodriguez-Chavez C, Larrea-Schiavon S, Leyva-Flores R, Bustamante N, Arevalo M, Cortes-Alcala R PLoS One. 2023; 18(2):e0282095.

PMID: 36812257 PMC: 9946200. DOI: 10.1371/journal.pone.0282095.

References
1.
Kosarkova A, Malinakova K, van Dijk J, Tavel P . Vaccine Refusal in the Czech Republic Is Associated with Being Spiritual but Not Religiously Affiliated. Vaccines (Basel). 2021; 9(10). PMC: 8537344. DOI: 10.3390/vaccines9101157. View

2.
Hardt K, Bonanni P, King S, Santos J, El-Hodhod M, Zimet G . Vaccine strategies: Optimising outcomes. Vaccine. 2016; 34(52):6691-6699. DOI: 10.1016/j.vaccine.2016.10.078. View

3.
Fernandez-Nino J, Cubillos-Novella A, Bojorquez I, Rodriguez M . Recommendations for the response against COVID-19 in migratory contexts under a closed border: The case of Colombia. Biomedica. 2020; 40(Supl. 2):68-72. PMC: 7676824. DOI: 10.7705/biomedica.5512. View

4.
Khaled S, Petcu C, Bader L, Amro I, Al-Hamadi A, Al Assi M . Prevalence and Potential Determinants of COVID-19 Vaccine Hesitancy and Resistance in Qatar: Results from a Nationally Representative Survey of Qatari Nationals and Migrants between December 2020 and January 2021. Vaccines (Basel). 2021; 9(5). PMC: 8151168. DOI: 10.3390/vaccines9050471. View

5.
Wouters O, Shadlen K, Salcher-Konrad M, Pollard A, Larson H, Teerawattananon Y . Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021; 397(10278):1023-1034. PMC: 7906643. DOI: 10.1016/S0140-6736(21)00306-8. View